Abstract:Marie-Odile Christen Behavior, Paris, France Correspondence: Marie-Odile Christen, Behavior, 27 Avenue Marceau, Paris, 75116, France, Tel +33 680998336, Email The number of aesthetic procedures performed worldwide continues to grow together with an increase in the population seeking the restoration or preservation of a youthful appearance. Requests for non-surgical body rejuvenation are increasing. Patients are looking for safe and effective minimally invasive aesthetic procedures. Soft-tissue dermal fillers can meet these expectations. Based on the beneficial outcomes of these treatments in many facial areas, a new trend is developing to target body areas. Different dermal fillers are available and include collagen stimulators initially developed to restore facial volume. Furthermore, they are associated with long-lasting efficiency, a high level of patient satisfaction and a good safety profile, with mainly minor adverse events reported. In appropriate conditions of use, they are now used for body rejuvenation in clinical practice. Their use is expanding and allows addressing various issues including volume loss, skin laxity, cellulite, striae distensae and wrinkles. This review focuses on poly-L-lactic acid (PLLA), used in the first collagen stimulator and one of the most investigated in facial and in off-facial body applications. The available published data, although still limited, are presented by body area, neck and chest, buttocks, abdomen, upper arms, thighs, knees, and hands. Key features of the concerned zones and the main clinical signs affecting the body part as well as the injection modalities are provided along with the aesthetic results. This represents the state of the art on which to base further developments necessary for optimal and safe outcomes of treatment with the PLLA-based collagen stimulators and others in this class for body rejuvenation. Keywords: poly-L-lactic acid, PLLA, volume augmentation, body contouring, dermal filler, collagen stimulator, buttocks, body rejuvenation, skin laxity, skin quality The number of patients seeking nonsurgical rejuvenation of the face and the body is continuing to increase due to a growing aging population concerned with physical appearance. Women wishing to maintain a younger-looking appearance and attractiveness represent 92% of all cosmetic procedures. 1 Men are keen to maintain physical characteristics associated with virility. 2 Millennials are also increasingly concerned with preserving their beauty and youth. 3 Among the various treatment approaches, different minimally invasive techniques have been developed and dermal fillers currently come second after botulinum toxin type A (BTA). 3 Their use is increasing worldwide. Dermal fillers allow the restoration of volume loss by filling the area concerned, to correct wrinkles, and to improve facial contours. The number of cosmetic procedures with dermal fillers has risen from 1.6 million in 2011 to 3.4 million in 2020. 1 In the resorbable category of dermal fillers, cross-linked hyaluronic acids (HA) come first in the ranking followed by collagen stimulators characterized by their property of inducing natural collagen production. The latter are made of either polymers, polycaprolactone (PCL; Ellansé, 30% microspheres; Sinclair Pharmaceuticals, London, UK), 4,5 Poly-L-lactic acid (PLLA, Sculptra 150 mg/vial; Galderma, La Tour-de-Peilz, Switzerland; 6–9 other PLLA-based product, Lanluma V [210 mg /vial] and Lanluma X [630 mg/vial], Sinclair Pharmaceuticals, London, UK), and of ceramics, calcium hydroxylapatite (CaHA, Radiesse 30% microspheres; Merz Aesthetics, Frankfurt am Main, Germany; 10–12 other CaHA-based product, Crystalys Luminera 55.7% microspheres; Allergan Aesthetics, an AbbVie group, USA). Besides their different compositions, formulations, product preparations and injection modalities, their main differences consist of their degradation kinetics, level of efficacy and duration of action. The aliphatic polyesters, PCL and PLLA, degrade slowly by hydrolysis of the ester bonds and have a long duration with PCL having the longest. 4,13–16 CaHA degrades more rapidly by a different mechanism. 10,12 Polymethyl methacrylate (PMMA, Bellafill 20% microspheres in bovine collagen, Suneva Medical, California, USA) is a permanent polymer, that had limited use in Europe given this characteristic. 17 All these products were originally developed for facial indications. Their use in body rejuvenation, initially performed using invasive methods such as surgery or lipofilling, was considered later on with the use of lasers and dermal fillers, along with the increasing patients' demand. 18 PLLA is a biocompatible, biodegradable and bioresorbable polymer. It is an alpha hydroxy acid p -Abstract Truncated-

Defining the core processes of psychotherapy.

Efficacy of an Innovative Poly-Component Formulation in Counteracting Human Dermal Fibroblast Aging by Influencing Oxidative and Inflammatory Pathways

Pilot study evaluating the therapeutic effects of a new pre-mixed injectable product of low molecular weight (LMW) hyaluronic acid added to six amino acids (HY6AA +Formula) in facial skin aging

The Clinical Evidence-Based Paradigm of Topical Anti-Aging Skincare Formulations Enriched with Bio-Active Peptide SA1-III (KP1) as Collagen Modulator: From Bench to Bedside

In vitro and in vivo Evaluation on the Safety and Efficacy of a Brand-New Intracutaneous Filler with α1-R-Collagen

Adipose Autologous Micrograft and Its Derived Mesenchymal Stem Cells in a Bio Cross-Linked Hyaluronic Acid Scaffold for Correction Deep Wrinkles, Facial Depressions, Scars, Face Dermis and Its Regenerations: A Pilot Study and Cases Report

Experimental and Clinical Efficacy of Two Hyaluronic Acid-based Compounds of Different Cross-Linkage and Composition in the Rejuvenation of the Skin

Typical metabolic traits of two Oenococcus oeni strains isolated from Valpolicella wines

HArmonyCa™ hybrid filler to restore connective tissue: An Italian real-life retrospective study

Clinical Evidence of Dermal and Epidermal Restructuring from a Biologically Active Growth Factor Serum for Skin Rejuvenation

HArmonyCaTM hybrid filler to restore connective tissue: An Italian real‐life retrospective study

Immediate and Long Term Clinical Benefits of a Novel Topical Micronized Collagen Face Cream

Morphometric analysis of the effects of high molecular weight sodium hyaluronate and amino acids mixture on face rejuvenation

Prospective, Randomized, Investigator-Blinded, Split-Face Evaluation of a Topical Crosslinked Hyaluronic Acid Serum for Post-Procedural Improvement of Skin Quality and Biomechanical Attributes

Collagen Stimulators in Body Applications: A Review Focused on Poly-L-Lactic Acid (PLLA)

Minimally Invasive Aesthetic Treatment of the Face and Neck Using Combinations of a PCL-Based Collagen Stimulator, PLLA/PLGA Suspension Sutures, and Cross-Linked Hyaluronic Acid

Biorevitalizing effect of a novel facial serum containing apple stem cell extract, pro‐collagen lipopeptide, creatine, and urea on skin aging signs

Evaluating the Properties of a Dual-Effect Facial Injectable: From Preclinical Data to Real-World Evidence

A collagen biostimulator improves photoaging pigmentation

A Novel Hyaluronic Acid Matrix Ingredient with Regenerative, Anti-Aging and Antioxidant Capacity

Facial Skin Rejuvenation Using Poly-dl-Lactic Acid Injected With a Laser-Generated Needle-Free Microjet Injector